首页> 外文会议>IEEE International Conference on Bioinformatics and Biomedicine >Identifying High-Risk Breast Cancer Patients Using Microarray and Clinical Data
【24h】

Identifying High-Risk Breast Cancer Patients Using Microarray and Clinical Data

机译:使用微阵列和临床数据鉴定高危乳腺癌患者

获取原文

摘要

The performance of DNA microarray in breast cancer prediction demonstrates the potential of genome-wide analysis using gene expression data. Therefore, this study proposed a prediction method called GridPCA to identify highrisk breast cancer patients using both microarray and clinical data. The GridSearch and Principal Component Analysis are employed in the proposed method to deal with the high dimensionality of microarray data. The experimental results showed that GridPCA achieved approximately 82% of average predictive accuracy with Decision Tree, K-Nearest Neighbour, Logistic Regression and Support Vector Machine classifiers. In future, the proposed method could be used in developing systems that help doctors in planning, decision making and tailoring appropriate treatments for increasing the survival rate of breast cancer patients.
机译:DNA微阵列在乳腺癌预测中的性能证明了使用基因表达数据的基因组分析的潜力。因此,该研究提出了一种称为Gridpca的预测方法,以鉴定使用微阵列和临床数据的高次乳腺癌患者。 GridSearch和主成分分析采用了拟议的方法来处理微阵列数据的高维度。实验结果表明,Gridpca与决策树,k最近邻,逻辑回归和支持向量机分类器实现了大约82%的平均预测精度。未来,该方法可用于开发系统,帮助医生在规划,决策和定制适当的治疗中,以增加乳腺癌患者的存活率。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号